Neurobiological effects of gallic acid: Current perspectives

MS Bhuia, MM Rahaman, T Islam, MH Bappi… - Chinese medicine, 2023 - Springer
Gallic acid (GA) is a phenolic molecule found naturally in a wide range of fruits as well as in
medicinal plants. It has many health benefits due to its antioxidant properties. This study …

Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer's disease: a systematic review of symptom-general and–specific lesion patterns

Y Chen, M Dang, Z Zhang - Molecular Neurodegeneration, 2021 - Springer
Neuropsychiatric symptoms (NPSs) are common in patients with Alzheimer's disease (AD)
and are associated with accelerated cognitive impairment and earlier deaths. This review …

Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders

T Prévot, E Sibille - Molecular psychiatry, 2021 - nature.com
Cognitive dysfunctions, including impaired attention, learning, memory, planning and
problem solving, occur in depressive episodes, often persist during remission, predict …

Understanding neuropsychiatric symptoms in Alzheimer's disease: challenges and advances in diagnosis and treatment

A Pless, D Ware, S Saggu, H Rehman… - Frontiers in …, 2023 - frontiersin.org
Neuropsychiatric symptoms (NPS) in Alzheimer's disease (AD) affect up to 97% of AD
patients, with an estimated 80% of current AD patients experiencing these symptoms …

The relationship between anxiety and Alzheimer's disease

MF Mendez - Journal of Alzheimer's disease reports, 2021 - journals.sagepub.com
Although Alzheimer's disease (AD) is primarily a neurocognitive disorder, it also results in
prominent neuropsychiatric symptoms (NPS). Much literature has investigated the NPS of …

Anxiety as a predictor for cognitive decline and dementia: a systematic review and meta-analysis

B Gulpers, I Ramakers, R Hamel, S Köhler… - The American Journal of …, 2016 - Elsevier
Background Because anxiety is postulated as a risk factor for dementia, we performed a
systematic review and meta-analysis to investigate whether anxiety predicts cognitive …

Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials

MW Weiner, DP Veitch, PS Aisen, LA Beckett… - Alzheimer's & …, 2017 - Elsevier
Abstract Introduction The Alzheimer's Disease Neuroimaging Initiative (ADNI) has continued
development and standardization of methodologies for biomarkers and has provided an …

High depression and anxiety in people with Alzheimer's disease living in retirement homes during the covid-19 crisis

M El Haj, E Altintas, G Chapelet, D Kapogiannis… - Psychiatry …, 2020 - Elsevier
To cope with Covid-19 and limits its spread among residents, retirement homes have
prohibited physical contact between residents and families and friend and, in some cases …

Apathy and anxiety are early markers of Alzheimer's disease

M Johansson, E Stomrud, O Lindberg, E Westman… - Neurobiology of …, 2020 - Elsevier
In this study, we investigated associations between neuropsychiatric symptoms (ie, apathy,
anxiety, and depression) and cerebral atrophy, white matter lesions (WML), beta-amyloid …

[HTML][HTML] The relationship between stress and Alzheimer's disease

NJ Justice - Neurobiology of stress, 2018 - Elsevier
Stress is critically involved in the development and progression of disease. From the stress
of undergoing treatments to facing your own mortality, the physiological processes that …